Print Issue: January 01, 2012

Hypofractionated Radiotherapy a Viable Option for Intermediate- to High-Risk Prostate Cancer

MIAMI BEACH, Fla.—Delivering higher daily doses of radiation in fewer days (hypofractionation) is as effective as conventional radiotherapy in preventing recurrence of intermediate- or high-risk prostate cancer (PCa) at five years after treatment, according to study findings presented at the American Society for Radiation Oncology annual meeting.

Next post in Prostate Cancer